Following the current crosstalk of TGF-β signaling and the underlying mechanisms identified here linking MT1-MMP, the promise of TGF-β targeted therapy or chemopreventive approaches, such as through diet-derived EGCG in malignant gliomas, is appealing (Figure 8). Here, TGFB1 is linked to malignant glioma.